zgc:55781 Antibody

What is zgc:55781 and why is it important in research?

zgc:55781 is a zebrafish gene with significant expression correlations to multiple genes involved in cellular metabolism and function. Based on correlation analysis, zgc:55781 demonstrates strong positive relationships with genes involved in ATP synthesis, calcium signaling, and oxidative stress management . Understanding zgc:55781 is particularly important for researchers studying zebrafish as a model organism for developmental biology, genetics, and disease modeling. The gene's expression pattern and correlation with mitochondrial components (such as atp5mc1, atp5mc3a, and atp5f1c) suggests potential involvement in energy metabolism pathways .

What is the expression profile of zgc:55781 across different developmental stages?

zgc:55781 appears to be broadly expressed based on the designation "all cells" in the Daniocell database . While specific developmental stage expression data isn't explicitly provided in the available resources, the correlation data suggests consistent co-expression with key metabolic genes. Researchers investigating the developmental regulation of this gene should consider analyzing its expression alongside positively correlated genes such as atp5mc1 (r=0.070), fabp7a (r=0.061), and atp5mc3a (r=0.059), which could provide insight into temporal expression patterns .

What approaches should be considered when designing antibodies against zgc:55781?

When designing antibodies against zgc:55781, researchers should consider several methodological approaches similar to those used for other complex proteins:

• Peptide-based approach: Generating antibodies using synthetic peptides (10-20 amino acids) conjugated to carrier proteins like keyhole limpet hemocyanin (KLH) . This approach is relatively straightforward but may not always recognize the native protein, especially for multi-transmembrane proteins.

• Full-length protein immunization: Using the complete zgc:55781 protein as an immunogen, though this presents challenges for expression and purification, particularly if zgc:55781 contains transmembrane domains .

• GST fusion protein approach: Utilizing glutathione S-transferase (GST) fusion proteins with unique antigenic fragments (~100 amino acids) of zgc:55781, which can improve immunogenicity while avoiding problematic regions like transmembrane domains .

Researchers should perform bioinformatic analysis of zgc:55781's topology before selecting the antigenic region to ensure optimal antibody generation .

How should bioinformatic analysis be applied to improve zgc:55781 antibody development?

Prior to antibody development, thorough bioinformatic analysis of zgc:55781 should be performed using multiple computational programs such as HMMTOP, MEMSAT, TOPCONS, and SPOCTOPUS to predict protein topology . These analyses should identify:

• Transmembrane domains (to be avoided in antigen design)

• Signal peptide sequences (to be avoided)

• Extracellular and intracellular domains

• Regions of high antigenicity and uniqueness

Consensus predictions from multiple algorithms provide more reliable topological models. For example, in similar protein studies, HMMTOP, MEMSAT, and TOPCONS consistently predicted six transmembrane domains with specific extracellular and cytoplasmic loops, while SPOCTOPUS predicted eight transmembrane helices . This type of analysis helps identify optimal regions for antibody targeting.

What expression systems are most appropriate for generating zgc:55781 antigens?

Based on methodologies used for similar proteins, researchers should consider the following expression systems for zgc:55781 antigen production:

• Bacterial expression systems (E. coli): Suitable for producing GST fusion proteins containing hydrophilic domains of zgc:55781. While this is the most common and cost-effective approach, it may present challenges for full-length membrane proteins due to toxicity, inclusion body formation, and lack of post-translational modifications .

• Mammalian expression systems: HEK293 cells can be used for overexpression of full-length zgc:55781 (potentially with epitope tags like FLAG) to generate antigens that maintain proper folding and post-translational modifications .

• Cell-free systems: For difficult-to-express proteins, cell-free translation systems might be considered as alternatives.

The choice depends on the protein characteristics and intended antibody application. For initial antibody development, the GST fusion protein approach in E. coli offers a good balance of feasibility and effectiveness .

What purification strategies are effective for zgc:55781 fusion proteins?

For optimal purification of zgc:55781 fusion proteins as immunogens, researchers should implement:

• Affinity chromatography: If using GST-tagged fusion proteins, glutathione sepharose can be employed for single-step purification. The process should include:

  • Column equilibration with binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na₂HPO₄, 1.8 mM KH₂PO₄, pH 7.3)

  • Incubation of bacterial lysates with sepharose (1 hour at 4°C)

  • Multiple washing steps with binding buffer

• On-column refolding: For insoluble proteins expressed as inclusion bodies, on-column refolding may improve antigen quality.

• Size exclusion chromatography: As a secondary purification step to remove aggregates and improve homogeneity.

Protein purity should be assessed via SDS-PAGE, and concentration determined using methods like RC DC protein assay before immunization .

What are the essential validation steps for newly generated zgc:55781 antibodies?

Comprehensive validation of newly generated zgc:55781 antibodies should include:

• Specificity testing:

  • Western blot analysis comparing wild-type samples to zgc:55781-deficient samples (if available)

  • Testing reactivity against overexpressed zgc:55781 in heterologous systems

  • Testing for cross-reactivity with closely related proteins

• Sensitivity assessment:

  • Determining detection limits using dilution series

  • Comparing signal intensity across tissues with known differential expression

• Application-specific validation:

  • For immunohistochemistry: testing with appropriate positive and negative control tissues

  • For immunoprecipitation: demonstrating specific pull-down of the target protein

  • For flow cytometry: comparing staining profiles with isotype controls

Validation should include testing in actual experimental conditions to ensure reliability of results in the intended research applications .

How should samples be prepared for optimal detection of zgc:55781 using antibodies?

Sample preparation protocols should be optimized based on the cellular localization and properties of zgc:55781:

• Tissue/cell lysis:

  • Use NETT buffer (150 mM NaCl, 5 mM EDTA, 10 mM Tris, 1% Triton X-100) with protease inhibitor cocktail

  • Determine protein concentrations using RC DC assay or similar methods

• For Western blotting:

  • Mix tissue lysates (40-60 μg/sample) with Laemmli buffer

  • Incubate at 37°C for 30 minutes (rather than boiling, which may cause aggregation of membrane proteins)

  • Separate proteins on SDS/10% polyacrylamide gels

  • Transfer to nitrocellulose membranes

• For immunohistochemistry:

  • Optimize fixation conditions (4% paraformaldehyde is common for zebrafish tissues)

  • Consider antigen retrieval methods if epitopes are masked

• Storage considerations:

  • Store tissue samples at -80°C immediately after collection

  • Avoid repeated freeze-thaw cycles of protein extracts

These optimized protocols improve detection sensitivity and reliability when working with zgc:55781 antibodies.

How can zgc:55781 antibodies be used to investigate protein-protein interactions?

Advanced investigation of zgc:55781 protein-protein interactions should consider:

• Co-immunoprecipitation (Co-IP) studies:

  • Use zgc:55781 antibodies to pull down the protein complex from zebrafish tissue lysates

  • Analyze interacting partners, particularly focusing on proteins with high correlation coefficients including atp5mc1 (r=0.070), fabp7a (r=0.061), and atp5mc3a (r=0.059)

  • Validate interactions with reciprocal Co-IP using antibodies against predicted interacting partners

• Proximity ligation assay (PLA):

  • Detect in situ protein interactions with spatial resolution

  • Particularly useful for investigating interactions with correlated proteins identified in the Daniocell database

• FRET/BRET analysis:

  • For dynamic interaction studies in living cells

  • Requires expression of fluorescently-tagged proteins

The correlation table from the Daniocell database provides a valuable starting point for investigating potential protein-protein interactions, with particular attention to proteins involved in ATP synthesis and calcium signaling pathways .

What strategies can help resolve contradictory results in zgc:55781 antibody studies?

When faced with contradictory results using zgc:55781 antibodies, researchers should systematically:

• Evaluate antibody specificity:

  • Perform epitope mapping to identify the exact binding site

  • Test multiple antibodies targeting different epitopes

  • Use genetic models (knockouts/knockdowns) as definitive controls

• Analyze experimental variables:

  • Compare buffer compositions and detergent concentrations

  • Evaluate fixation methods and their impact on epitope accessibility

  • Consider differences in sample preparation temperature (37°C incubation versus boiling)

• Assess post-translational modifications:

  • Investigate whether discrepancies result from differential protein modification

  • Use phosphatase or glycosidase treatments to determine if modifications affect antibody recognition

  • Consider tissue-specific or condition-specific modifications

• Implement orthogonal methods:

  • Complement antibody-based detection with mass spectrometry

  • Use genetic tagging approaches (CRISPR knock-in) for independent validation

These systematic approaches help resolve contradictions and improve experimental reproducibility.

How should zgc:55781 expression be interpreted in relation to correlated genes?

Interpreting zgc:55781 expression in relation to its correlated genes requires sophisticated analytical approaches:

Researchers should:

• Perform pathway enrichment analysis:

  • Note that positively correlated genes cluster in energy metabolism (ATP synthesis), calcium signaling, and stress response pathways

  • Negatively correlated genes show enrichment in lipid metabolism and developmental transcription factors

• Consider developmental context:

  • Correlations may reflect tissue-specific co-regulation

  • Temporal expression patterns may reveal developmental programs

• Implement network analysis:

  • Construct interaction networks based on correlation data

  • Identify hub genes that may regulate coordinated expression

• Design experiments to test functional relationships:

  • Use morpholino or CRISPR approaches to manipulate zgc:55781 expression

  • Measure effects on correlated genes to determine causality versus correlation

These analytical approaches transform correlation data into testable hypotheses about zgc:55781 function.

How can single-cell analysis approaches enhance zgc:55781 antibody research?

Single-cell analysis technologies offer powerful new approaches for zgc:55781 research:

• Single-cell proteomics:

  • Use zgc:55781 antibodies in mass cytometry (CyTOF) for single-cell protein quantification

  • Combine with antibodies against correlated proteins to map protein networks at cellular resolution

• Spatial transcriptomics integration:

  • Correlate zgc:55781 protein localization (via immunofluorescence) with spatial transcriptomics data

  • Map expression patterns in the context of tissue architecture and developmental stages

• Multimodal analysis:

  • Implement CITE-seq approaches combining antibody detection with transcriptomics

  • Correlate protein levels with mRNA expression to identify post-transcriptional regulation

• In situ antibody sequencing:

  • Apply emerging technologies for in situ protein detection with spatial resolution

  • Map zgc:55781 distribution across tissues with subcellular precision

These approaches provide unprecedented resolution for understanding zgc:55781 function in complex biological contexts.

What are the methodological considerations for studying zgc:55781 in zebrafish disease models?

When investigating zgc:55781 in zebrafish disease models, researchers should:

• Design appropriate genetic models:

  • Generate conditional knockouts using Cre-lox systems similar to the Ubc-Cre approach described for related studies

  • Use tissue-specific promoters to restrict manipulation to relevant cell types

  • Consider knockin models with epitope tags for antibody-independent detection

• Optimize immunohistochemistry protocols:

  • Adapt fixation methods (paraformaldehyde concentration and duration) for zebrafish tissues

  • Implement antigen retrieval techniques optimized for aquatic model organisms

  • Use tyramide signal amplification for improved sensitivity in whole-mount samples

• Implement longitudinal analysis:

  • Design non-terminal sampling methods for tracking zgc:55781 changes over disease progression

  • Consider transgenic reporter lines for live imaging of pathway activity

• Validate findings across models:

  • Compare results between morpholino knockdown, CRISPR knockout, and pharmacological modulation

  • Establish concordance between zebrafish models and mammalian systems

These methodological considerations ensure robust, reproducible findings when studying zgc:55781 in disease contexts.